Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
NCT ID: NCT05910489
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
25 participants
OBSERVATIONAL
2024-09-30
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomonitoring of Occupationally Populations Exposed to Micro and Nanoplastic
NCT06323603
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs
NCT05679544
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT03839537
The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
NCT01599845
TEXTO : Total EXposure To Organic Pollutants
NCT02210299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This observational study will obtain body samples of greenhouse workers and from a control group. That would allow optimizing specific biomarkers of human MNPLs exposure and the characterization of biomarkers of early effect that allows an association among the exposure to MNPLs and effects on human health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Biomonitoring studies to detect MNPLs in biological samples and study of health effects.
Determination of MNPLs levels, genotoxic damage, and immunological effects
Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces
Greenhouse workers
Biomonitoring studies to detect MNPLs in biological samples and study of health effects.
Determination of MNPLs levels, genotoxic damage, and immunological effects
Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 18 years old
* Absence of chronic pathology including neoplasia
* Absence of infectious disease at the date of sample collection and for a period of more than 2 weeks
* Spanish residence
* Age over 18 years old. Matched by age, gender, and lifestyle to the exposed group.
* Absence of chronic pathology including neoplasia
* Absence of infectious disease at the date of sample collection and for a period of more than 2 weeks
* Spanish residence
Exclusion Criteria
* Pregnancy
* Unsigned informed consent
* Participation in another clinical study
* Pregnancy
* Unsigned informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
OTHER
Hospital Universitario Virgen de la Arrixaca
OTHER
Ricard Marcos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricard Marcos
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pablo Pelegrín
Role: PRINCIPAL_INVESTIGATOR
Instituto Murciano de Investigación Biosanitaria (IMIB)
Juan Bernardo Cabezuelo
Role: STUDY_CHAIR
Hospital Clínico Universitario Virgen de Arrixaca (Murcia)
Laura Martínez
Role: STUDY_CHAIR
Hospital Clínico Universitario Virgen de Arrixaca (Murcia)
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.